Meldol, their newest addition to the pharmaceutical market, aims to provide reliable relief from pain and fever.
Formulated with high-quality raw-material, it is designed to offer reliable alleviation of various types of pain, including headaches, muscle aches, and dental pain, as well as to reduce fever.
Available in convenient tablet form, Meldol is expected to become a popular choice for those seeking a reliable and efficient pain relief solution.
The launch ceremony held at Ekala was graced by President Ranil Wickremesinghe, Minister of Tourism, Land, Sports and Youth Affairs, Harin Fernando, Chief of Staff and National Security Advisor to the President, Sagala Ratnayake, former Minister of Health, Nutrition and Indigenous Medicine and incumbent Parliamentarian, Dr Rajitha Senaratne, and Directors of the Melwa Conglomerate and many other esteemed guests.
During the event, the new Cephalosporin Injectable Plant owned by Sands Active Pvt. Ltd., was also inaugurated by the President.
The Plant signifies a major leap forward for Sri Lanka's pharmaceutical sector.
This state-of-the-art facility will significantly boost the nation's ability to produce high-quality injectable antibiotics, essential for treating a variety of bacterial infections.
Cephalosporins are a critical class of antibiotics in modern medicine, frequently used in hospitals to treat severe infections such as pneumonia, meningitis, and sepsis.
Founded in 2018 as a conglomerate of Melwa, Sri Lanka's premier steel product manufacturer, Sands Active Pvt. Ltd. focuses on manufacturing and distributing high-quality pharmaceutical products, including oral tablets, capsules, injectable medicines for the local market, adhering to international standards.
In collaboration with the State Pharmaceutical Manufacturing Corporation (SPMC), they strive to make healthcare products both accessible and cost-effective for the community.
Committed to maintaining the highest quality standards, Sands Active ensures that their products and processes comply with both local and international regulations.
They adhere to guidelines set by the World Health Organisation (WHO), the EU-GMP and other relevant bodies, and their products are certified by the National Medicines Regulatory Authority (NMRA).